Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe β-Thalassemia Patients
Wei-Jia Yang,1,* Lian-dong Shi,2,* Ye Liang,3,* Li-ming Liang,4,* Hao Zhang,5 Li Wang,2 Qian Zhou1 1Department of Eugenics and Genetics, Guilin People’s Hospital, Guilin, Guangxi Zhuang Autonomous Region, 541002, People’s Republic of China; 2Department of Ultrasound,...
Saved in:
| Main Authors: | Yang WJ, Shi LD, Liang Y, Liang LM, Zhang H, Wang L, Zhou Q |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-11-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/comparison-of-efficacy-and-safety-outcomes-of-different-doses-schedule-peer-reviewed-fulltext-article-TCRM |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Follow-Up of Patients Undergoing Thalidomide Therapy for Transfusion-Dependent β-Thalassemia: A Single Thalassemia Center Cohort Study
by: Kiran Kanwal, et al.
Published: (2025-07-01) -
THALIDOMIDE FOR PATIENTS WITH THALASSEMIA INTERMEDIA: A RETROSPECTIVE MULTICENTER CLINICAL STUDY
by: Kun Yang, et al.
Published: (2020-04-01) -
Thalidomide as Treatment of Lip’s Pyogenic Granuloma
by: Lai L, et al.
Published: (2025-03-01) -
A Triple Therapeutic Regiment Consisted of Colchicine, Thalidomide and Total Glucosides of Paeony Is Effective and Well‐Tolerated for Treating Mucocutaneous Involvement in Patients With Behcet's Disease
by: Jian‐Fei Cai, et al.
Published: (2024-12-01) -
A review of thalidomide and digestive system related diseases
by: Zhao Xi, et al.
Published: (2025-05-01)